Host Genome Methylation: a Screening Tool in Anal Cancer Detection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Host Genome Methylation: a Screening Tool in Anal Cancer Detection	Anal Cancer, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, female reproductive system disorder, female reproductive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, vulva cancer, vulvar disease	Recruiting	Not applicable	2025-01-24		NCT06792604

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Assistance Publique - Hôpitaux de Paris	985

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cardiovascular Surgery and Transplantation Department Bichat-Claude Bernard Hospital	Paris	France	1
Dermatology Department	Paris	France	1
Gynecology and Obstetrics Department Bichat-Claude Bernard Hospital	Paris	France	1
Hepato-Gastroenterology, Digestive Oncology, and Proctology Department Bichat-Claude Bernard Hospital	Paris	France	1
Infectious and Tropical Diseases Department Bichat-Claude Bernard Hospital	Paris	France	1
Nephrology Department Bichat-Claude Bernard Hospital	Paris	France	1
Pathological Anatomy and Cytology Department Bichat-Claude Hospital	Paris	France	1
Pulmonology B and Lung Transplantation Department Bichat-Claude Bernard Hospital	Paris	France	1
Virology Department Bichat-Claude Bernard Hospital	Paris	France	1